Phibro Animal Health Corp. (PAHC) News

Phibro Animal Health Corp. (PAHC): $15.40

0.30 (+1.99%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter PAHC News Items

PAHC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

PAHC News Highlights

  • For PAHC, its 30 day story count is now at 4.
  • Over the past 13 days, the trend for PAHC's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • CEVA and PAY are the most mentioned tickers in articles about PAHC.

Latest PAHC News From Around the Web

Below are the latest news stories about PHIBRO ANIMAL HEALTH CORP that investors may wish to consider to help them evaluate PAHC as an investment opportunity.

Implied Volatility Surging for Phibro (PAHC) Stock Options

Investors need to pay close attention to Phibro (PAHC) stock based on the movements in the options market lately.

Yahoo | January 17, 2023

Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2022 Quarterly Financial Results

Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its second quarter financial results on Wednesday, February 8, 2023, after the mark

Business Wire | January 9, 2023

Farm Animal Healthcare Global Market Report 2022: Ukraine-Russia War Impact

Major players in the farm animal healthcare market are Bayer Healthcare, Boehringer Ingelheim, Ceva Animal Health, Elanco, Merck, Merial (Sanofi), Virbac, Zoetis Animal Healthcare, Vetoquinol, Norbrook, Alivira Animal Health Limited, Phibro Animal Health, Intas Pharmaceuticals Ltd, Hester Bioscience, and Eli Lilly and Company. Major players in the farm animal healthcare market are Bayer Healthcare, Boehringer Ingelheim, Ceva Animal Health, Elanco, Merck, Merial (Sanofi), Virbac, Zoetis Animal Healthcare, Vetoquinol, Norbrook, Alivira Animal Health Limited, Phibro Animal Health, Intas Pharmaceuticals Ltd, Hester Bioscience, and Eli Lilly and Company.

GlobeNewswire | January 4, 2023

Phibro (PAHC) Q1 Earnings Miss Estimates, Sales Surpass

Phibro's (PAHC) growing uptake of MFAs, dairy products and vaccines buoys optimism.

Yahoo | November 16, 2022

Phibro Animal Health Corporation (PAHC) Q1 2023 Earnings Call Transcript

Phibro Animal Health Corporation (NASDAQ:NASDAQ:PAHC) Q1 2023 Earnings Conference Call November 10, 2022, 9:00 AM ET Company Participants Damian Finio - Chief Financial Officer Jack…

Seeking Alpha | November 13, 2022

Phibro Animal Health Corporation 2023 Q1 - Results - Earnings Call Presentation (NASDAQ:PAHC)

The following slide deck was published by Phibro Animal Health Corporation in conjunction with their 2023 Q1 earnings call.

Seeking Alpha | November 13, 2022

Phibro Animal Health (NASDAQ:PAHC) Has Announced A Dividend Of $0.12

Phibro Animal Health Corporation ( NASDAQ:PAHC ) will pay a dividend of $0.12 on the 21st of December. The dividend...

Yahoo | November 12, 2022

Phibro Animal Health First Quarter 2023 Earnings: EPS Misses Expectations

Phibro Animal Health ( NASDAQ:PAHC ) First Quarter 2023 Results Key Financial Results Revenue: US$232.5m (up 8.3% from...

Yahoo | November 11, 2022

Phibro Animal Health (PAHC) Misses Q1 Earnings Estimates

Phibro (PAHC) delivered earnings and revenue surprises of -19.23% and 3.71%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 10, 2022

Phibro Animal Health Corporation Reports First Quarter Results, Revised Guidance

TEANECK, N.J., November 09, 2022--Phibro Animal Health Corporation (Nasdaq: PAHC) ("Phibro" or the "Company") today announced financial results for its first quarter ended September 30, 2022, and reiterated its financial guidance for Net sales and Adjusted EBITDA and revised its guidance for Net income, Diluted EPS, Adjusted net income, Adjusted diluted EPS and Adjusted effective tax rate for the year ending June 30, 2023.

Yahoo | November 9, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5235 seconds.